The vktx stock price's 50-day moving average has just crossed above its 200-day average — a “golden cross” signal favored by trend-following investors. This could imply medium-term strength in Viking Therapeutics’ equity. Viking Therapeutics, Inc. (VKTX) closed at $65.85 in the latest trading session, marking a +0.72% move from the prior day. The stock's change was more than the S&P 500's daily gain of 0.47%. On the other hand, the Dow registered a gain of 0.79%, and the technology-centric Nasdaq increased by 0.28%. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #4 (Sell) for Viking Therapeutics. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> vktx stock price continues to attract institutional inflows, as 13F filings indicate increased holdings from major healthcare-focused funds. This buying activity supports price stability during market dips.
Return this item within 90 days of purchase.
Get an immediate answer with AI
AI-generated from the text of manufacturer documentation. To verify or get additional information, please contact The Home Depot customer service.